Search Page
Save citations to file
Email citations
Email address has not been verified. Go to
My NCBI account settings
to confirm your email and then refresh this page.
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2025 | 1 |
Search Results
2 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study).
J Antimicrob Chemother. 2017 Jan;72(1):246-253. doi: 10.1093/jac/dkw379. Epub 2016 Sep 13.
J Antimicrob Chemother. 2017.
PMID: 27629070
Free article.
Clinical Trial.
Clinical outcomes of long-acting cabotegravir and rilpivirine in people with HIV aged 60 and older: Real-world data from the Spanish RELATIVITY cohort.
Troya J, Montes ML, Galindo MJ, Santiago AD, Lagarde M, Rodríguez D, Rodríguez A, Crussels MJ, Torralba M, Hidalgo C, Fanjul F, Soler JF, Gisbert L, Díez C, Pérez D, Romero A, Ferreira EM, Cabo R, Rúiz-Alonso N, Escrich C, Sepúlveda MA, Padilla S, Corte JJ, Pedrero-Tomé R; RELATIVITY Group; Buzón L.
Troya J, et al.
HIV Med. 2025 Oct 21. doi: 10.1111/hiv.70114. Online ahead of print.
HIV Med. 2025.
PMID: 41118425
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.